Tumor Models Market Outlook 2026–2030 advancing cancer research capabilities

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Tumor Models Market From 2026 To 2030?

The tumor models market has observed rapid expansion in recent years. It is anticipated to grow from $2.13 billion in 2025 to $2.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.3%. The historical increase in this market was influenced by factors such as the limited availability of advanced tumor models, the reliance on traditional 2D cell cultures, growing cancer research funding, the increasing prevalence of cancer, and the adoption of orthotopic and heterotopic models.

The tumor models market is anticipated to experience significant expansion in the coming years, with its size projected to reach $3.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.8%. This growth throughout the forecast period is largely attributable to advancements in organ-on-a-chip and 3D spheroid technologies, an increasing focus on personalized oncology treatments, the expansion of contract research organizations (CROs) involved in tumor research, rising pharmaceutical R&D expenditure, and the integration of AI and big data analytics into tumor model studies. Major trends for the forecast period include the increasing use of 3D tumor spheroids and organ-on-a-chip models, a growing demand for personalized medicine and targeted cancer therapies, the broadening application of xenograft and genetically engineered mouse models (GEMMs), an increase in drug discovery and toxicology studies leveraging tumor models, and enhanced collaboration between pharmaceutical companies and academic institutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

What Key Drivers Are Influencing The Growth Of The Tumor Models Market?

The increasing need for personalized medicine is anticipated to drive expansion in the tumor models market in the future. Personalized medicine is defined as a healthcare approach that leverages an individual’s genetic and lifestyle data to customize treatments and medical care according to their unique requirements. The growth of personalized medicine stems from a consumer preference for health technologies that provide real-time monitoring and treatment strategies tailored to individual biological profiles. Tumor models support personalized medicine by serving as experimental platforms that replicate the behavior of human cancers, enabling researchers and clinicians to assess and forecast how specific treatments will affect individual patients’ tumors, thereby facilitating a more customized therapeutic strategy. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, marking a notable rise from the 12 approved in 2022. Consequently, the expanding demand for personalized medicine is fueling the development of the tumor models market.

Which Segments Are Included In The Analysis Of The Tumor Models Market?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Which Trends Are Impacting The Growth Of The Tumor Models Market?

Leading companies in the tumor models market are concentrating on developing sophisticated solutions, such as tumor spheroid models, to enhance the physiological relevance and predictive accuracy of in vitro cancer models. These tumor spheroid models are three-dimensional (3D) aggregates of cancer cells that spontaneously form spherical structures in culture. For example, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, introduced novel 3D cell technology to accelerate cancer therapeutic drug discovery. This technology offers distinct features, including advanced 3D tumor spheroid and organoid models that closely mimic the tumor microenvironment, high-throughput screening capabilities for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics for improved predictive accuracy and deeper insights into therapeutic responses.

Which Key Industry Participants Are Active In The Tumor Models Market?

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Read the full tumor models market report here:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Tumor Models Market?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Tumor Models Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2026, By The Business Research Company

Voice Payment Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795